SCHEMBL4905993

SCHEMBL4905993

CCN(c1ccc(OCc2ccccc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
MMP9 P14780 2/20 0.52
MMP13 P45452 2/20 0.52
ADAM17 P78536 2/20 0.52
ESR1 P03372 3/20 0.51
ALDH1A1 P00352 3/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TSHR P16473 1/20 0.49
PTPN1 P18031 1/20 0.49
PTPN12 Q05209 1/20 0.49
PTPN22 Q9Y2R2 1/20 0.49
KEAP1 Q14145 2/20 0.48
NFE2L2 Q16236 2/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
PKM P14618 1/20 0.48
MAPT P10636 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895352 0.93 KMT2A (0.54) LMNAMMP9MMP13ADAM17ESR1
SCHEMBL4905129 0.91 MMP13 (0.52) LMNAMMP9MMP13ADAM17ESR1
SCHEMBL4907030 0.91 LMNA (0.51) LMNAMMP9MMP13ADAM17ESR1
SCHEMBL4897482 0.91 LMNA (0.53) LMNAMMP9MMP13ADAM17ESR1
SCHEMBL4895594 0.91 LMNA (0.50) LMNAMMP9MMP13ADAM17ESR1
SCHEMBL4904188 0.89 LMNA (0.53) LMNAMMP9MMP13ADAM17ESR1
SCHEMBL4905308 0.88 MMP2 (0.49) LMNAMMP9MMP13ALDH1A1HPGD
SCHEMBL4903420 0.87 LMNA (0.57) LMNAMMP9MMP13ADAM17ESR1
SCHEMBL4902654 0.87 LMNA (0.61) LMNAESR1ALDH1A1HPGDALOX15
SCHEMBL4895518 0.85 MMP9 (0.48) MMP9MMP13ADAM17KEAP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885MMP9 4632/4885MMP13 3079/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885MMP9 4632/4885MMP13 3079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.